Full Year 2018 Cosmo Pharmaceuticals NV Earnings Call Transcript
Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals Full Year Results 2018 Conference Call. I'm Andrei, Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to management team of Cosmo Pharmaceuticals. You will be now joined to the conference room.
Good morning, and thank you for being here at our full year report presentation for the year 2018. Let me state one thing, which we think is nice and should be taken as a good thing, Cosmo's got now 3 approved products that comes from the same MMX technology. We started with Lialda, then we went further with Uceris and now finally, Aemcolo, our new antibiotic, has been approved, and we are quite proud of this achievement. We've been trying to understand if there are actually companies that have 3 or more products approved with the very same technology, and we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
